Company Filing History:
2 out of 832,961 Years Active: 2002
Title: William Thomas Muldoon: Innovator in Controlled Release Formulations
Introduction
William Thomas Muldoon is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. With a total of 2 patents, Muldoon has focused on innovative solutions for treating complex medical conditions.
Latest Patents
Among his latest patents, Muldoon has developed a controlled release dosage form of a specific acetonitrile compound. This formulation is designed for the treatment and/or prophylaxis of certain disorders. Additionally, he has created a composition aimed at treating dementia and Alzheimer's disease. This controlled release dosage form is particularly useful in enhancing amyloid precursor protein processing along a non-amyloidogenic pathway in patients at risk of developing Alzheimer's disease.
Career Highlights
Throughout his career, Muldoon has demonstrated a commitment to advancing medical science through his innovative work. His patents reflect a deep understanding of pharmacology and the complexities of drug delivery systems. His contributions have the potential to improve the quality of life for many patients suffering from debilitating conditions.
Collaborations
Muldoon has collaborated with esteemed colleagues such as Joseph Peter Sauer and Susan Marie Milosovich. These partnerships have likely enriched his research and development efforts, leading to the successful creation of his patented formulations.
Conclusion
William Thomas Muldoon stands out as a significant figure in the realm of pharmaceutical innovations. His work in controlled release formulations showcases his dedication to improving treatment options for serious health conditions.